Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5537070 | 0.73 | MAPT (0.37) | KDM4ERAB9A | |
| SCHEMBL5537072 | 0.73 | CYP2A6 (0.36) | KDM4ERAB9ATDP1 | |
| SCHEMBL218556 | 0.71 | GPR3 (0.35) | GPR3 | |
| SCHEMBL5535514 | 0.71 | KDM4E (0.37) | ALDH1A1KDM4EMEN1RAB9AKMT2A | |
| SCHEMBL4463876 | 0.71 | CA4 (0.32) | GPR3ALDH1A1KDM4EMEN1PKM | |
| SCHEMBL5540484 | 0.70 | RAB9A (0.32) | ALDH1A1MAPK1RAB9A | |
| SCHEMBL5535813 | 0.70 | GFER (0.35) | ALDH1A1KDM4EMEN1PKMMAPK1 | |
| SCHEMBL1450632 | 0.70 | CYP2A6 (0.33) | ALDH1A1KDM4E | |
| SCHEMBL5535516 | 0.70 | CYP2A6 (0.40) | ALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL5540480 | 0.70 | HSP90AA1 (0.33) | ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265103-A1 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | TME THERAPEUTICS LLC | 2023-08-24 | — | — | US | claimed |
| CN-1152108-C | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | claimed |
| CN-1152109-C | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | claimed |
| CN-1328108-A | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | claimed |
| CN-1328109-A | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | claimed |
| CN-118221745-A | Organometallic compound, organic light emitting diode including the same, and organic light emitting device | 乐金显示有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20230265103-A1 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | TME THERAPEUTICS LLC | 2023-08-24 | — | — | US | disclosed |
| CN-109311844-B | Triazine compound, method for producing same, and organic electroluminescent element containing same as constituent component | 东曹株式会社 | 2021-07-20 | — | — | CN | disclosed |
| CN-112912372-A | Cyclic azine compound, material for organic electroluminescent element, electron transport material for organic electroluminescent element, and organic electroluminescent element | 东曹株式会社 | 2021-06-04 | — | — | CN | disclosed |
| WO-2020085319-A1 | CYCLIC AZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2020-04-30 | — | — | WO | disclosed |
| WO-2019163959-A1 | CYCLIC AZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCNET ELEMENT, AND ELECTRON-TRANSPORTING MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2019-08-29 | — | — | WO | disclosed |
| CN-106905312-A | With to Hg2+Continuously selective asymmetric perfluoro-cyclopentene compound and its preparation method and application with Cys | 江西科技师范大学 | 2017-06-30 | — | — | CN | disclosed |
| CN-1152108-C | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | disclosed |
| CN-1152109-C | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | disclosed |
| EP-1386923-A1 | NOVEL ADENINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2004-02-04 | — | — | EP | disclosed |
| CN-1328108-A | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | disclosed |
| CN-1328109-A | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | disclosed |
| US-6268514-B1 | TREATING INDUSTRIAL MATERIALS WITH NITROETHANE COMPOUND FOR PROTECTING AGAINST ATTACK AND DESTRUCTION BY MICROORGANISMS | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-31 | — | — | US | disclosed |
| US-5654309-A | KIDNEY, CARDIOVASCULAR AND RESPIRATORY SYSTEM DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-08-05 | — | — | US | disclosed |
| EP-0608565-A1 | Pyridopyrimidine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265103-A1 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | PIKFYVE, PIK3CD, PIK3R5 | GPR3 3242/4885ALDH1A1 4836/4885KDM4E 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.